JP2022503733A5 - - Google Patents
Info
- Publication number
- JP2022503733A5 JP2022503733A5 JP2021515005A JP2021515005A JP2022503733A5 JP 2022503733 A5 JP2022503733 A5 JP 2022503733A5 JP 2021515005 A JP2021515005 A JP 2021515005A JP 2021515005 A JP2021515005 A JP 2021515005A JP 2022503733 A5 JP2022503733 A5 JP 2022503733A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- pharmaceutically acceptable
- administered
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862746943P | 2018-10-17 | 2018-10-17 | |
| US62/746,943 | 2018-10-17 | ||
| PCT/US2019/056772 WO2020081839A1 (en) | 2018-10-17 | 2019-10-17 | Methods and compositions for treating oral mucositis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022503733A JP2022503733A (ja) | 2022-01-12 |
| JP2022503733A5 true JP2022503733A5 (enExample) | 2022-10-26 |
Family
ID=70281364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021515005A Pending JP2022503733A (ja) | 2018-10-17 | 2019-10-17 | 口腔粘膜炎を治療するための方法および組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11123357B2 (enExample) |
| EP (1) | EP3866810A4 (enExample) |
| JP (1) | JP2022503733A (enExample) |
| KR (1) | KR20210075968A (enExample) |
| CN (1) | CN112839662A (enExample) |
| AU (1) | AU2019361999A1 (enExample) |
| BR (1) | BR112021006954A2 (enExample) |
| CA (1) | CA3116157A1 (enExample) |
| IL (1) | IL282100A (enExample) |
| MX (1) | MX2021004396A (enExample) |
| SG (1) | SG11202103180QA (enExample) |
| WO (1) | WO2020081839A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12030908B2 (en) | 2017-03-10 | 2024-07-09 | Lakewood Amedex, Inc. | Antimicrobial compounds, compositions, and uses thereof |
| US11795192B2 (en) * | 2017-03-10 | 2023-10-24 | Lakewood Amedex, Inc. | Antimicrobial compounds, compositions, and uses thereof |
| WO2024129985A2 (en) * | 2022-12-14 | 2024-06-20 | Lakewood Amedex, Inc. | Antiviral compounds, compositions, and uses thereof |
| WO2025179296A1 (en) * | 2024-02-22 | 2025-08-28 | Lakewood Amedex, Inc. | Crystalline forms of nu-3 and uses thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4421769A (en) | 1981-09-29 | 1983-12-20 | The Procter & Gamble Company | Skin conditioning composition |
| US5167950A (en) | 1991-03-28 | 1992-12-01 | S. C. Johnson & Son | High alcohol content aerosol antimicrobial mousse |
| CZ267396A3 (en) | 1994-03-11 | 1997-03-12 | Procter & Gamble | HYDROLYTIC STABLE COSMETIC, PREPARATION WITH LOW pH VALUE CONTAINING ACID ACTIVE SUBSTANCES |
| US6211162B1 (en) | 1998-12-30 | 2001-04-03 | Oligos Etc. Inc. | Pulmonary delivery of protonated/acidified nucleic acids |
| US20020032164A1 (en) | 1998-12-30 | 2002-03-14 | Dale Roderic M. K. | Antimicrobial compounds and methods for their use |
| US7868162B2 (en) | 1998-12-30 | 2011-01-11 | Lakewood-Amedex, Inc. | Antimicrobial and antiviral compounds and methods for their use |
| US6211349B1 (en) | 1998-12-30 | 2001-04-03 | Oligos Etc., Inc. | Protonated/acidified nucleic acids and methods of use |
| ES2234563T5 (es) | 1999-02-12 | 2018-01-17 | Daiichi Sankyo Company, Limited | Nuevos análogos de nucleósidos y oligonucleótidos |
| US6946118B1 (en) * | 1999-09-14 | 2005-09-20 | Orapharma, Inc. | Formulations for treating or preventing mucositis |
| US6156294A (en) | 1999-11-28 | 2000-12-05 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
| JP2005511526A (ja) | 2001-10-18 | 2005-04-28 | イレックス プロダクツ インコーポレイテッド | ジホスホネート誘導体による皮膚の治療方法 |
| US20030236217A1 (en) * | 2002-05-21 | 2003-12-25 | Shalwitz Robert A. | Treatment of mucositis |
| CN1687100A (zh) * | 2005-04-05 | 2005-10-26 | 奥林格斯技术有限公司 | 修饰性核苷酸及其用途 |
| US8227431B2 (en) | 2008-03-17 | 2012-07-24 | Hetero Drugs Limited | Nucleoside derivatives |
| US8884000B2 (en) | 2010-02-17 | 2014-11-11 | Albert Einstein College Of Medicine Of Yeshiva University | Saporin-L1 inhibitors and uses thereof |
| WO2012017434A2 (en) * | 2010-08-03 | 2012-02-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Compounds for treating bacterial infections |
| AU2013264820A1 (en) * | 2012-05-23 | 2014-11-27 | Cellixbio Private Limited | Compositions and methods for treatment of mucositis |
| WO2014124430A1 (en) | 2013-02-11 | 2014-08-14 | Emory University | Nucleotide and nucleoside therapeutic compositions and uses related thereto |
| WO2015075406A1 (en) | 2013-11-19 | 2015-05-28 | Lipopeptide Ab | New treatment of chronic ulcers |
| AU2015338969B2 (en) | 2014-10-30 | 2020-08-27 | Biomet Manufacturing, Llc | Methods of preventing surgical site infections |
| US10172786B2 (en) * | 2014-12-16 | 2019-01-08 | Axim Biotechnologies, Inc. | Oral care composition comprising cannabinoids |
| WO2017165673A1 (en) * | 2016-03-23 | 2017-09-28 | University Of Utah Research Foundation | Spinal traction device |
| KR102317158B1 (ko) * | 2017-03-10 | 2021-10-25 | 레이크우드 아메덱스, 인크. | 항미생물 화합물, 조성물, 및 그의 용도 |
| KR20260035292A (ko) * | 2017-06-12 | 2026-03-12 | 레이크우드 아메덱스, 인크. | 비스포스포신 겔 제제 및 이의 용도 |
-
2019
- 2019-10-17 BR BR112021006954-2A patent/BR112021006954A2/pt not_active Application Discontinuation
- 2019-10-17 JP JP2021515005A patent/JP2022503733A/ja active Pending
- 2019-10-17 MX MX2021004396A patent/MX2021004396A/es unknown
- 2019-10-17 SG SG11202103180QA patent/SG11202103180QA/en unknown
- 2019-10-17 KR KR1020217004939A patent/KR20210075968A/ko not_active Abandoned
- 2019-10-17 CA CA3116157A patent/CA3116157A1/en active Pending
- 2019-10-17 CN CN201980068116.XA patent/CN112839662A/zh active Pending
- 2019-10-17 US US16/656,129 patent/US11123357B2/en not_active Expired - Fee Related
- 2019-10-17 AU AU2019361999A patent/AU2019361999A1/en not_active Abandoned
- 2019-10-17 WO PCT/US2019/056772 patent/WO2020081839A1/en not_active Ceased
- 2019-10-17 EP EP19874581.2A patent/EP3866810A4/en not_active Withdrawn
-
2021
- 2021-04-06 IL IL282100A patent/IL282100A/en unknown
- 2021-08-27 US US17/459,248 patent/US20210393666A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022503733A5 (enExample) | ||
| JP2021066744A5 (ja) | ブプロピオンおよびデキストロメトルファンを含む組成物 | |
| JP2019189650A5 (enExample) | ||
| JP2017214429A5 (enExample) | ||
| JP2016517431A5 (enExample) | ||
| JP3597333B2 (ja) | 急性鼻炎を処置するための医薬製剤 | |
| JP2013513612A5 (enExample) | ||
| JP2009544665A5 (enExample) | ||
| JP2012520882A5 (enExample) | ||
| JP2016512246A5 (enExample) | ||
| JPWO2023054732A5 (enExample) | ||
| JP6461002B2 (ja) | 口腔局所用組成物 | |
| KR890003382A (ko) | 항 비루스성 화합물 | |
| JP2020510085A5 (enExample) | ||
| JP2021073194A5 (enExample) | ||
| JP2012508256A5 (enExample) | ||
| MX2024014315A (es) | Compuestos amido heteroaromaticos utiles en el tratamiento de enfermedades hepaticas | |
| JP2590156B2 (ja) | 経口投与用医薬組成物 | |
| RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
| RU2012149868A (ru) | Полисахарид семян для применения в лечении воспалительных заболеваний | |
| RU2005105302A (ru) | Композиция бицифадина | |
| JP2011529936A5 (enExample) | ||
| JP2012526099A5 (enExample) | ||
| JP2022500445A5 (enExample) | ||
| JP2015081244A (ja) | ニキビ治療用医薬組成物 |